Article
Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy.
Diabetes - 1 Nov 2009
McGuire James F, Rouen Shefali, Siegfreid Eric, Wright Douglas E, Dobrowsky Rick T
Abstract excerpt
OBJECTIVE: Evaluate if Erb B2 activation and the loss of caveolin-1 (Cav1) contribute to the pathophysiological progression of diabetic peripheral neuropathy (DPN). RESEARCH DESIGN AND METHODS: Cav1 knockout and wild-type C57BL/6 mice were rendered diabetic with streptozotocin, and changes in motor nerve conduction velocity (MNCV), mechanical and thermal hypoalgesia, Erb B2 phosphorylation (pErb B2), and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
